All major pharmaceutical and biotech companies require an adaptive platform which would provide a clear view of flow of company’s Gross-to-Net financials. The “Gross to Net” (GTN), in its essence captures droppage accounted via promotional discounts and rebates
Viscadia has developed a GTN calculation platform to analyse the demand and pricing KPIs in an all–encompassing interactive GTN dashboard. It is designed to address all nuances related to federal rebates per US government policies.
Accommodated various channels across nodes of distribution network during the flow of drug from manufacturer to the patient
Incorporated operational nuances in the tool for different federal and non-federal channels to derive respective rebates/ discounts
Created a robust methodology to enable the user to function at Stock Keeping Unit (SKU) as well as Standard Unit (SU) level across various channels
Ensured tool is equipped to forecast GTN for forthcoming years thus enabling user to devise well-informed strategies
Created a one stop repository for all the KPIs, related to GTN, for downstream usage by finance and forecast teams
Provided functionality that provides user the flexibility to configure and compare different what-if scenarios on the fly